Patents by Inventor Cassie L. Harvey

Cassie L. Harvey has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of treating inflammatory bowel disease by administering a clip-inducing agent
    Patent number: 8906846
    Abstract: The disclosure relates to methods for treating disorders of the mucosal tract such as the gastrointestinal system by targeting CLIP molecules. The methods are based on that CLIP in the groove of MHC class I or II molecules of the cells lining the mucosal surfaces of the body, such as the gastrointestinal tract, provides protection from MHC Class II or MHC class I mediated cell death, and therefore are useful for treating, inhibiting the development of a multitude of illnesses and conditions of the mucosal tract, including autoimmune disease.
    Type: Grant
    Filed: January 5, 2012
    Date of Patent: December 9, 2014
    Assignees: The Texas A&M University System, Scott & White Healthcare
    Inventors: Martha Karen Newell, Cassie L. Harvey, Richard Tobin
  • MHC ENGAGEMENT AND CLIP MODULATION FOR THE TREATMENT OF DISEASE
    Publication number: 20140220000
    Abstract: The invention relates to methods for treating disorders by targeting CLIP molecules and MHC. The methods are useful for treating, inhibiting the development of, or otherwise dealing with diseases such as HIV, blood vessel proliferative disorder, cancer and fibrosis.
    Type: Application
    Filed: April 4, 2012
    Publication date: August 7, 2014
    Applicants: Scott & White Healthcare, The Texas A&M University System
    Inventors: Martha Karen Newell, Cassie L. Harvey, Richard Tobin
  • CLIP MODULATION FOR THE TREATMENT OF MUCOSAL DISEASES
    Publication number: 20130295047
    Abstract: The disclosure relates to methods for treating disorders of the mucosal tract such as the gastrointestinal system by targeting CLIP molecules. The methods are based on that CLIP in the groove of MHC class I or II molecules of the cells lining the mucosal surfaces of the body, such as the gastrointestinal tract, provides protection from MHC Class II or MHC class I mediated cell death, and therefore are useful for treating, inhibiting the development of a multitude of illnesses and conditions of the mucosal tract, including autoimmune disease.
    Type: Application
    Filed: January 5, 2012
    Publication date: November 7, 2013
    Applicants: Scott & White Healthcare, The Texas A&M University System
    Inventors: Martha Karen Newell, Cassie L. Harvey, Richard Tobin